Nowadays, it is vital to have new, complete, and rapid methods to screen and follow pharmacotoxicological and forensic cases. In this context, an important role is undoubtedly …
V Greco, M Locatelli, F Savini, U Grazia, O Montanaro… - Separations, 2023 - mdpi.com
The primary cause of poor and ambiguous results obtained from the bioanalytical process is the sample pre-treatment, especially in clinical analysis because it involves dealing with …
S Barco, A Mesini, L Barbagallo, A Maffia… - … of Pharmaceutical and …, 2020 - Elsevier
Background The accurate measurement of plasma levels of antibiotics is crucial for the individualization of antimicrobial therapies based on PK/PD strategies. In this paper we …
D Ferrari, M Locatelli - 2020 - econtent.hogrefe.com
The world is currently overwhelmed by a novel coronavirus disease (COVID-19). Clinically, COVID-19 shows a broad range of manifestations: from asymptomatic to severe and …
C Feliu, C Konecki, T Candau, D Vautier… - Pharmaceuticals, 2021 - mdpi.com
Potential under-or overdose of antibiotics may occur in intensive care units due to high variability in plasma concentrations. The risk is either treatment failure or toxicity. Thus …
W Lu, M Pan, H Ke, J Liang, W Liang, P Yu… - Frontiers in …, 2022 - frontiersin.org
Antimicrobial resistance (AMR) is a major threat to global health due to the wide use of antibacterial drugs. Multiple studies show that the pharmacokinetic/pharmacodynamic …
H Sun, H Xing, X Tian, X Zhang… - Journal of Analytical …, 2022 - Wiley Online Library
Pharmacokinetics/pharmacodynamics is the foundation for guiding the rational application of antibiotics in clinical practice, so it is necessary to establish quantitative methods for …
L Liu, L Zhang, X Zheng, X Liu, W Liu… - Frontiers in …, 2023 - frontiersin.org
Empirically prescribed standard dosing regimens of antibacterial agents may result in insufficient or excess plasma concentrations with persistently poor clinical outcomes …
W Li, Y Li, J Cai, Y Wang, Y Liu, H Hu, L Liu - Pharmaceuticals, 2023 - mdpi.com
Systemic antifungal agents are essential for high-risk patients undergoing immunosuppressive therapy or cancer chemotherapy because of the rapid increase in …